Abstract
NAP1L1 is a key regulator of embryonic neurogenesis but its role in lung cancer remains unexplored. In this study, we investigated the relationship between NAP1L1 expression and the clinicopathological parameters and prognosis of non-small cell lung cancer patients. To this end, the expression of NAP1L1 in tumor samples was evaluated by immunohistochemistry. NAP1L1 expression was significantly associated with reduced differentiation (P = 0.00014), higher pathological TNM stages (P < 0.00001), lymph node metastasis (P < 0.00001), intrapulmonary metastasis (P = 0.02955), lymphatic invasion (P = 0.00019), vascular invasion (P = 0.00008) and poorer prognosis (P = 0.0008) of patients with adenocarcinoma. Moreover, multivariate analyses using the Cox-proportional hazards model confirmed that NAP1L1 expression increased the risk of death after adjusting for other clinicopathological factors (HR = 2.46, 95% CI, 1.22-4.96). Furthermore, NAP1L1 expression was identified as an independent poor prognostic factor in patients with resectable stage I lung adenocarcinoma. NAP1L1-siRNA-treated lung adenocarcinoma-derived A549 cells showed significant suppression of proliferation, migration, and invasion abilities. These findings suggest that NA...Continue Reading
References
Jul 1, 1982·The American Journal of Surgical Pathology·R W McDivittD Gersell
Oct 18, 2002·Cancer Immunology, Immunotherapy : CII·Aija LineRobert C Rees
Jun 6, 2003·Biochemical and Biophysical Research Communications·Kentaro OhkuniAkihiko Kikuchi
Jan 21, 2006·Annals of Surgical Oncology·Mark KiddIgor Latich
Jun 24, 2006·Annals of Surgery·Irvin M ModlinRobert L Camp
Feb 24, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jordanka ZlatanovaMiroslav Tomschik
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
May 20, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ryo NagashioTakashi Nakajima
Oct 22, 2008·Gastroenterology·Augusto VillanuevaJosep M Llovet
Jan 22, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisDavid Yankelewitz
Dec 3, 2011·Molecular BioSystems·Francesca GuidiLuigi Messori
Oct 4, 2012·Archives of Biochemistry and Biophysics·Mikaël AttiaUte Christine Rogner
Oct 13, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Hee Jin LeeMyoung Sik Han
Dec 7, 2013·Journal of Hepatology·Matthias S MatterSnorri S Thorgeirsson
Feb 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H JohnsonPaul A Bunn
Jul 30, 2014·Epigenetics & Chromatin·Simon SchimmackMark Kidd
Aug 15, 2014·Oncology Letters·Hiroshi HiranoMasahide Mori
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 1, 2017·Journal of Virology·Recep Emrah ÇevikAlessandro Marcello
Jul 9, 2017·Biochimica Et Biophysica Acta. Molecular Cell Research·Toshiaki TanakaKaoru Goto
Jan 31, 2018·Nature Reviews. Immunology·Koji Taniguchi, Michael Karin
Mar 1, 2018·Cell Reports·Huimin QiaoJianwei Jiao
Mar 25, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zhiqiang ChenXuehao Wang
Jun 6, 2018·Frontiers in Oncology·Norashikin ZakariaBadrul Hisham Yahaya
Sep 14, 2019·Cancer Cell International·Yong LeMing Shi